Skip to main content

Table 2 Characteristics of breast cancers in kidney transplant recipients

From: Early diagnosis and treatment of breast cancer in Japanese kidney transplant recipients: a single center experience

Patients

Age

Duration to diagnosis (months)

screening test

MMG positive

USG positve

Procedure

Pathology

Stage

Positivity of hormone receptor

Recurrence

Status

Follow-up duration

1

59

343

+

+

+

CS

solid-tubular carcinoma

1

ER(−),PR(−),HE2(+)

-

Alive

79

2

56

262

+

+

+

CS

solid-tubular carcinoma

1

N/A

-

Dead

56

3

58

270

+

+

+

CS

non invasive ductal carcinoma

0

ER(−),PR(−),HE2(+)

-

Alive

69

4

46

66

-

-

-

MRM

solid-tubular carcinoma

1

ER(−)

-

Alive

187

5

42

57

+

+

+

CS

papillotubular carcinoma

1

HE2(+)

-

Alive

142

6

48

48

+

-

+

CS

papillotubular carcinoma

1

ER(+),PR(−),HE2(−)

-

Alive

113

7

41

113

+

+

+

CS

solid-tubular carcinoma

1

ER(+),PR(−),HE2(+)

-

Alive

24

8

35

80

+

-

+

CS

papillotubular carcinoma

0

ER(+),PR(+),HE2(+)

-

Alive

43

9

44

99

+

+

+

MRM

non invasive ductal carcinoma

2A

ER(+),PR(+),HE2(+)

-

Alive

5

  1. MGM: Mammography, USG: Ultrasonography.
  2. CS: Conservative surgery, MRM: Modified radical mastectomy.
  3. ER: Estrogen receptor, PR: Progesteron receptor, HER2: Human EFGR related-2.